Feedback (GB:FDBK) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Feedback PLC has announced that its Bleepa platform, which facilitates Diagnostic Enhanced Advice and Guidance, is now eligible for reimbursement under the NHS Elective Recovery Fund, potentially boosting its commercial prospects. This development allows Integrated Care Boards and hospitals in England to secure funding for Bleepa, aiming to reduce patient wait times and streamline healthcare services. The company has also partnered with Moorhouse Consulting to expedite the implementation of this solution across the NHS, potentially generating significant revenue through increased adoption.
For further insights into GB:FDBK stock, check out TipRanks’ Stock Analysis page.
